Championing Diversity, Equity and Inclusion

At Sanofi, we want to reflect the diversity of our communities, unleashing our whole selves every day to transform the practice of medicine. We want to make an impact in the world through who we are, what we do, and the way we do it, and we recognize that the only way to really do this is to do it together and by being “All In”.

Diversity, Equity and Inclusion are integral to Sanofi’s Play to Win strategy. They help us reinvent how we work and drive our cultural transformation through:

Building Representative Leadership: We must build leadership teams that reflect the diversity of the communities we serve so we can leverage a wider range of perspectives and be more fully connected to our patient, employee, customer, and stakeholder needs.
Creating a Work Environment where we can bring the best of our whole selves: Through diversity, equity and inclusion, our employees must feel able to unleash their full potential so we can foster creativity and innovation.
Engaging With Our Diverse Communities: to change the practice of medicine, we must be citizens of the world, advocating for inclusion and diversity with our external stakeholders.

How we Maximize Opportunities

By raising awareness and deepening understanding. We address diversity, equity, and inclusion in our own communication, and catalyze conversations at all levels to drive greater equity of gender, culture and origins, LGBTQ+, generations, and ability.
By enhancing creativity and innovation. We build teams that reflect the diversity of our employees, as we believe combining the distinct identities of our people and business partners is a source of strength and a key ingredient of our success.
By making sure our workplaces are accessible. We ensure accessibility on our sites, provide inclusive technologies, and promote ways of working that will allow all employees to be fully productive.
By committing to better represent the diversity of patients in our clinical trials.
By increasing the inclusion of historically under-represented groups in our sourcing processes through Sanofi’s supplier diversity program

How we Minimize Risks

We have zero tolerance for harassment (e.g. physical, sexual, psychological, verbal, or of any other form) and discrimination on the basis of: gender, identity, age, origin, religion, race, heritage, sexual orientation, physical appearance, health disability, trade union activity, political opinions, nationality, family situation or on any other grounds.
We prohibit any conduct that may negatively affect a person’s dignity.
We avoid homogeneity by providing employees with the support they need to guarantee that their voices are heard.

As our purpose is to improve people’s lives, we are committed to upholding respect for every individual around the world. This includes the physical and psychological health, safety, and wellbeing of Sanofians as well as our respect for human rights and freedoms, labor rights, and decent work among all people.

Respecting People, Fostering Psychological Safety and Wellbeing

As our purpose is to improve people’s lives, we are committed to upholding respect for every individual around the world. This includes the physical and psychological health, safety, and wellbeing of Sanofians as well as our respect for human rights and freedoms, labor rights, and decent work among all people.

Within Sanofi, we create an environment where everyone can feel safe and supported to bring their whole self to work. This enables innovation and creativity, so we can pursue progress for the people we serve.

We want every Sanofian to have a purposeful experience. That’s why we make physical and psychological health, safety, and wellbeing a priority. Our “All Well” approach includes:

Healthy minds: supporting emotional and mental wellbeing;
Healthy working culture: building a culture that is respectful, supportive and inclusive at all levels;
Healthy financials: helping each of us manage and stay in control of our finances at all stages of life; and
Healthy body: supporting good physical health, focusing on prevention and quality healthcare

We understand that for Sanofians to embrace Play to Win behaviors, we need to:

secure a foundation of physical and psychological health and safety;
build mutual and interpersonal trust; and
enable our employees to feel safe, speak-up, and take thoughtful risks.

These goals align with our Organizational Justice principles on speaking up and reporting concerns to promote a safe, positive working environment.

We extend our respect to all people through our commitment to the United Nations (UN) Universal Declaration of Human Rights, the UN Guiding Principles on Business and Human Rights, and the International Labour Organization (ILO) Declaration on Fundamental Principles and Rights at Work alongside ILO Fundamental Conventions.

How we Maximize Opportunities

We are building psychological health and safety at every level of our organization through learning and development opportunities to increase engagement, performance and the motivation to take thoughtful risks to bring innovative solutions.
We are encouraging more feedback and delivering more impact by measuring and tracking levels of psychological safety through annual surveys.
We support physical wellbeing and a healthy lifestyle through various initiatives such as Move Often, Eat Well, Stay Healthy, and Sanofi’s quality healthcare programs, offering many practical tools, awareness campaigns and prevention programs.
Our Employee Assistance Program includes advice on psychological, financial, and legal topics, ensuring our people always have somewhere to turn to should they struggle in their personal or professional lives.
We are fostering a healthy working culture by implementing a working environment where our people feel empowered to perform, safe to raise their voice, and supported, whoever and wherever they are, through programs such as Gender-Neutral Parental Leave.
By supporting the education of our employees, business partners, and stakeholders as well as the dissemination of accurate and routine information to patients and stakeholders through diverse channels, we advance innovation and scientific knowledge and understanding while empowering individuals to improve human health.

How we Minimize Risks

We prevent psycho-social risks through various initiatives. These include awareness programs, diagnostic tools to detect early manifestations as well as mental health education and a 24/7 global Employee Assistance support hotline.
We provide support to minimize the impact and risk of unfortunate life events. We provide our employees with tools and resources to help them stay in control of and plan for their future.
We facilitate a culture of speaking up without fear of retaliation. Our people should feel confident in the knowledge that a raised concern will be investigated and, if warranted, followed by actions that treat all concerned fairly and justly, in line with our organizational justice principles.
We respect internationally recognized human rights and freedoms, labor rights and decent work, seeking to advance them wherever we can.

At Sanofi, we want to reflect the diversity of our communities, unleashing our whole selves every day to transform the practice of medicine. We want to make an impact in the world through who we are, what we do, and the way we do it, and we recognize that the only way to really do this is to do it together and by being “All In”.

Safeguarding Data Privacy and Protecting Information

Sanofi is committed to data privacy and information security at every level of our organization for the benefit of patients, our employees, and stakeholders and to ensure full compliance with regulatory obligations.

Digital transformation and data processing capabilities are strengthening how Sanofi interacts with people and organizations to achieve our purpose. Processing data, from collection to storage, is now a key component of our relationship with patients, healthcare professionals, members of the scientific community, customers and users of our products and services, and our employees and business partners. To safeguard data privacy, we have implemented a Global Privacy Governance Framework that ensures optimal protection of personal data. We have also adopted a Cybersecurity and Security Framework to maintain the security and confidentiality of our information technology systems, assets, information, and databases.

How we Maximize Opportunities

By implementing and constantly enhancing best practices in data privacy and information security, Sanofi builds trust in and provides legal certainty for our vital data and sensitive information ecosystem.
By providing expertise, guidance and support to our employees and stakeholders, we help them make the right decisions when collecting, processing, and sharing personal data, in line with our values.
By applying a risk-based approach in designing proportionate controls to maintain operational efficiency while meeting the privacy expectations of patients, individuals and regulators.
By enabling Sanofi’s digital strategy through providing innovative tools and guidance, we implement privacy-by-design and data security as of the initial stages of each project.
By developing a pro-active approach to data privacy, we align our objectives and foster confidence with data protection authorities and other regulatory bodies.

How we Minimize Risks

We recognize the variations of regulations in the countries where we operate and we implement a Global Privacy Governance Framework and Information Protection policies, consisting of standards, procedures, templates and tools designed to ensure compliance with applicable privacy laws and security standards.
We prevent security events through specific procedures as well as physical, logical, organizational, and technical measures and dedicated programs to address insider-risk and external threats.
We actively detect and manage security and privacy events such as cyberattacks, personal data breaches and data subject rights requests, ensuring relevant parties are informed and supported.
We ensure each project involving personal data applies privacy-by-design and transparency principles through a step-by-step compliance roadmap.
We conduct due diligence and active monitoring to help ensure Sanofi only works with reliable business partners when transferring personal data inside or outside the company while ensuring that adequate contractual measures are implemented to safeguard all transfers.
We appoint a network of privacy officers and champions across Sanofi to provide practical expertise and support where and when it matters and to coordinate with our stakeholders.
We increase general awareness through education and communication to reinforce our culture of privacy and information protection, making us more resilient to security threats.

Sanofi strives to deliver better outcomes for patients, communities, and stakeholders by providing groundbreaking therapies at the right time and for the right reasons. We support a level playing field in which companies freely and fairly chase the miracles of science without undue advantage.
Sanofi does not tolerate any form of bribery or abuse of power for personal gain, both among our employees and business partners, as well as among stakeholders involved in chasing the miracles of science to improve patients’ lives.
At Sanofi, we ensure that our stakeholders can hear from and engage with us, including through social media and digital platforms. We recognize this requires us to communicate responsibly and are fully committed to doing so.
We are committed to the integrity of Sanofi’s financial activities to realize our purpose, ensuring our role as a trusted partner in serving public health needs and expanding health innovation. Financial integrity is vital to protect the patients we serve as well as our employees, stakeholders, and the financial markets.

Commercialization of Products and Services

Sanofi is committed to the sustainable and long-term success of our company aligned with our strategy. In order to uphold our purpose and ambition, we work with all stakeholders to help ensure our commercialization approach promotes patient and societal welfare, complies with laws and regulations, and operates ethically and with integrity.

We develop innovative products and services that help to prevent, diagnose, and treat diseases, thus improving people’s lives. Across the entire product lifecycle, we are committed to high ethical standards, earning patients’ and stakeholders’ trust. Chasing the miracles of science to improve people’s lives requires a life sciences ecosystem that rewards innovation and ensures that all patients who need our products and services have access to them. We are committed to bringing forward new products and services with a sense of urgency and continuously improving those products and services as well as our business processes.

How we Maximize Opportunities

By pursuing a commercialization approach that drives vital resources towards meeting underserved health needs, improving research and development, strengthening supply chain resilience, and expanding access for current and future patient welfare.
By working with diverse stakeholders in order to commercialize the very best products and services possible, so that we maximize benefits for patients.

How we Minimize Risks

We take a commercial approach for new products which is rooted in our Global Access and Pricing Principles, which take into account four criteria:
- overall added value of the products
- availability or anticipated availability of similar treatments
- ability of countries to afford new medicines
- unique factors specific to the medicine or vaccine at the time of launch
We strive for rapid, broad and equitable access to our products and services, regardless of an individual’s ability to pay.
We are transparent in our commercialization approach, including in such areas as the information we provide about our products and the disease states they impact, the data we collect and our product supply.
We promote our products and services ethically, with integrity and in compliance with applicable laws and regulations. We design communications about our products and services to be accurate, balanced, and not misleading.

Sanofi is committed to transparent communication about its products, while ensuring information about the efficacy, safety profile and services are routinely updated.
At Sanofi, we are committed to conducting our research and development activities with integrity and providing relevant information transparently to facilitate the proper use of our products.

Engaging Business Partners

At Sanofi, we engage with a variety of business partners that we expect to uphold the highest ethical standards.

Our engagement with business partners including suppliers, customers and third-party sales and marketing intermediaries, strategic alliances and joint ventures is rooted in trust and is crucial to our work, enabling opportunities for Sanofi to achieve its purpose. It can also present a variety of risks to our operations, finances, and reputation, particularly when a business partner does not adhere tox Sanofi’s Code of Conduct.

How we Maximize Opportunities

By only engaging with suppliers who adhere to our Code of Conduct, we strengthen our performance, mitigate potential disruptions, and foster an ethical health ecosystem that benefits patients.
By supporting Sanofi’s employees so they can confidently collaborate with our business partners with an understanding of shared values and standards of conduct.
By fostering the success of small and medium-sized business partners who share our values and standards of conduct, supporting their growth alongside Sanofi.
By embracing business partners that are as diverse as the patients and communities we serve, fostering an equitable and inclusive health ecosystem that supports Sanofi’s growth and creativity.
By coordinating with our industry peers and trade associations to strengthen ethical principles among shared business partners, we foster higher standards across our business sector.

How we Minimize Risks

We engage with business partners based on objective criteria, including demonstrated competence and a record of integrity consistent with our Code of Conduct, while ensuring fair and non-discriminatory procurement practices.
Prior to their selection, we undertake risk-based due diligence on our business partners.
We expect all business partners to comply with all applicable laws and regulations and to adhere to the Sanofi’s Code of Conduct, including maintaining appropriate policies and procedures for their partnership role with Sanofi. In addition, we expect our suppliers to adhere to our Supplier Code of Conduct.
We utilize controls that include regular monitoring, training, auditing, and other assessments to help detect, prevent, and remediate actual or potential non-compliant activities by our business partners.
We communicate to our business partners our requirements, which we expect them to adhere to.
We undertake cross-functional collaboration throughout Sanofi in the lifecycle management of our business partners.
We enable our business partners, when faced with a potential non-compliant situation in connection with Sanofi business, to report it via the Speak-Up Helpline.

Our approach to social impact is to strengthen, reaffirm, and amplify our commitment to society and the communities we serve. Our social impact is enabled by three efforts:
Sanofi is committed to maintaining patient focus as well as acting with integrity, respect, legitimate intent, transparency, and accountability when interacting with stakeholders.

Competing Freely and Fairly

Sanofi strives to deliver better outcomes for patients, communities, and stakeholders by providing groundbreaking therapies at the right time and for the right reasons. We support a level playing field in which companies freely and fairly chase the miracles of science without undue advantage.

Sanofi supports laws promoting fair competition and trade practice, as well as a vital ecosystem of innovation. We comply with all these laws wherever we do business and never attain competitive advantage through unethical or illegal business practices. This includes our commitment to never engage or appear to engage in the disparaging of our competitors, the imposition of restrictions on suppliers or customers, or an abuse of a dominant position in the market through improper agreements or any sort of collusion with competitors.

How we Maximize Opportunities

By competing freely and fairly, Sanofi upholds innovation, drives quality, and expands choice for patients, improving health outcomes and meeting the expectations of our stakeholders and society as a whole.
By supporting and advocating for a level playing field, Sanofi helps the best treatments reach the patients who need them while supporting the sustainability of our industry.
By advocating for and protecting intellectual property rights that are vital to upholding an ecosystem that rewards investment in innovation. Sanofi also recognizes that any dominant market position that results from such rights be respected by healthcare regulators through facilitating patient access.
By partnering with diverse stakeholders, as well as our trade association partners and conference organizers to uphold free and fair competition.

How we Minimize Risks

We rely on a strong network of experts around the world to ensure compliance with all laws and regulations upholding free and fair competition, and apply our ethical principles where laws may fall short to support a level playing field.
We prohibit our employees and business partners from pursuing activities with our competitors, suppliers, or customers that would result in Sanofi gaining an undue advantage.

Sanofi is committed to data privacy and information security at every level of our organization for the benefit of patients, our employees, and stakeholders and to ensure full compliance with regulatory obligations.
Sanofi does not tolerate any form of bribery or abuse of power for personal gain, both among our employees and business partners, as well as among stakeholders involved in chasing the miracles of science to improve patients’ lives.
At Sanofi, we ensure that our stakeholders can hear from and engage with us, including through social media and digital platforms. We recognize this requires us to communicate responsibly and are fully committed to doing so.
We are committed to the integrity of Sanofi’s financial activities to realize our purpose, ensuring our role as a trusted partner in serving public health needs and expanding health innovation. Financial integrity is vital to protect the patients we serve as well as our employees, stakeholders, and the financial markets.

Fighting Bribery and Corruption

Sanofi does not tolerate any form of bribery or abuse of power for personal gain, both among our employees and business partners, as well as among stakeholders involved in chasing the miracles of science to improve patients’ lives.

Such acts of bribery and corruption include providing (or receiving) anything of value to (or from) any person for the purpose of influencing any behavior or decision, particularly healthcare professionals, patient organizations, government officials, and state organizations. Corruption harms patients, erodes trust in healthcare, and can curtail investment in medicines. Corruption also fosters health inequities and deters economic development, human rights, and environmental sustainability. Our intolerance for any kind of corruption drives Sanofi to cultivate a robust culture of integrity. It also motivates us to fight corruption outside our organization wherever it may hinder our purpose.

How we Maximize Opportunities

By preventing bribery and corruption, both within Sanofi and across all those that touch our sector, this enables the company to realize its purpose and ensure the sustainability of our industry by upholding innovation, driving high quality of products and services, and safeguarding public and private resources to improve health outcomes and meet society’s expectations.
By demonstrating our trustworthiness to patients and our stakeholders through our commitment to preventing bribery and corruption internally and our determination to fight it externally.
By empowering our people to proactively identify, assess, and mitigate potential bribery and corruption risks and prioritize our resources to manage them.
By engaging in joint or multi-party initiatives across the biopharmaceutical industry as well as in partnership with patients, healthcare professionals, civil society, and multi-lateral organizations to fight corruption and strengthen the resilience of health systems.

How we Minimize Risks

We prohibit our employees or business partners from engaging in any act or perceived act of bribery and corruption. We require them to report any potential act of bribery and corruption while routinely training our employees to help identify and prevent such acts.
We prohibit facilitating payments, even when legally permitted.
We prohibit employees giving or receiving gifts from third parties.
We safeguard processes for and eliminate barriers to an employee or business partner’s ability to raise and report bribery or corruption concerns confidentially with protections against retaliation.
We support a robust ethics and compliance function that can execute its responsibilities independently and has direct access to executive leadership.
We utilize our experienced experts around the world to ensure adherence to all anti-bribery and anti-corruption laws and regulations, as well as to apply our ethical principles where laws may fall short of upholding the highest standards of business integrity.
We conduct risk-based anti-bribery due diligence on our business partners, including suppliers, customers, and third-party sales and marketing intermediaries, before engaging them and periodically during our partnering. Any potential issue raised through this monitoring is reviewed and assessed in order to evaluate the need for a risk mitigation plan, including termination if required.

Sanofi is committed to data privacy and information security at every level of our organization for the benefit of patients, our employees, and stakeholders and to ensure full compliance with regulatory obligations.
Sanofi strives to deliver better outcomes for patients, communities, and stakeholders by providing groundbreaking therapies at the right time and for the right reasons. We support a level playing field in which companies freely and fairly chase the miracles of science without undue advantage.
At Sanofi, we ensure that our stakeholders can hear from and engage with us, including through social media and digital platforms. We recognize this requires us to communicate responsibly and are fully committed to doing so.
We are committed to the integrity of Sanofi’s financial activities to realize our purpose, ensuring our role as a trusted partner in serving public health needs and expanding health innovation. Financial integrity is vital to protect the patients we serve as well as our employees, stakeholders, and the financial markets.

Protecting the Environment

Climate change is one of the most pressing challenges of our time. Sanofi’s immediate and long-term success requires decisive leadership to protect our planet and the natural air, land, and water environment that humanity depends on.

At Sanofi, our dedication to improving people’s lives goes beyond innovations in healthcare. As a global organization we also bear great responsibility to take actions that mitigate the consequences of climate change on human health today and for future generations, including food and water shortages, reduced air quality, and conditions that support the spread of diseases and allergies. These actions include minimizing the environmental impact of our products and activities as well as supporting others in similar efforts. We are also strengthening our own resilience in the face of environmental changes.

How we Maximize Opportunities

By aligning every decision we make with the expectations of the world’s patients, our employees and stakeholders, including investors and governments, to protect the environment.
By building the road to carbon neutrality by 2030, reducing emissions across our full value chain to the maximum by 2045, and finally offsetting what cannot be reduced, we will contribute to limit global warming to 1.5°C.
By limiting our environmental footprint and adopting circular solutions that conserve energy and reduce waste, we support the conservation and sustainability of our planet’s finite air, land, and water resources.
By improving the environmental profile of our products and services, ensuring their sustainability as the world mobilizes to address climate change and encouraging others within our sector to take similar action.
By reducing the negative impact of climate change on human health, supporting the prevention of premature death; air pollution-related illnesses such as respiratory infections, heart diseases, and lung cancers; consumption or contact with contaminated water that causes gastrointestinal illness and allergies; and climate-sensitive health outcomes such as extreme heat events, floods, droughts, and fires.
By supporting and developing employees and business partners who care and act for the well-being of the planet and serving as an enterprise with leading environmental principles.
By assessing climate change-related opportunities for our business, to develop robust strategies unlocking transition potentialities.

How we Minimize Risks

We prioritize environmentally conscious decision-making throughout all levels of the organization and incentivize behavior consciously choosing to protect the environment.
We prevent contamination and damage to the environment through the implementation of policies and practices that reflect our values as an ecologically responsible company.
We prevent diseases associated with environmental contamination through actions within and outside Sanofi that have a positive impact on society and our diverse communities.
We make decisions that prioritize our values in environmental protection and sustainability.
We reduce reputational risk and loss of stakeholder confidence by having an unquestionable and transparent commitment to caring for the environment, which we reflect in clear and concise actions that we disclose publicly with truthful and complete information.
We prioritize environmental protection in the selection of our business partners.
We assess climate change-related risks on our operations and value chain, to develop robust mitigation strategies.

Our approach to social impact is to strengthen, reaffirm, and amplify our commitment to society and the communities we serve. Our social impact is enabled by three efforts:

Committing to Society

Our approach to social impact is to strengthen, reaffirm, and amplify our commitment to society and the communities we serve. Our social impact is enabled by three efforts:

Corporate Social Responsibility, a company-wide strategy aligned to our long-term business strategy, designed to make a difference that can be scaled and delivering positive impact that can be sustained over time. Every part of the organization has a role to play and makes a contribution with flagship initiatives spread across the company’s value chain, from R&D to manufacturing to commercial operations
Global Health Unit (GHU), a non-profit enterprise that makes essential Sanofi products available in low- and middle-income countries as well as supports local entrepreneurs scale up healthcare capacity; and
Foundation S – The Sanofi Collective, our “Think and Do Tank” philanthropic arm that improves the lives of vulnerable populations by catalyzing community–based solutions around childhood cancer, climate action and health resilience, neglected tropical diseases, and responding to humanitarian crises by donating medicines and offering emergency aid.

How we Maximize Opportunities

By recognizing that our purpose includes a fundamental commitment to all our stakeholders to improve people’s health, to deliver value to customers, to invest in our employees, to deal fairly and ethically with our suppliers, to support the communities in which we work, and to generate long-term value for shareholders.
By increasing access to and affordability of our products and services, including through patient programs and other initiatives, we strengthen communities and their healthcare systems, particularly for the most vulnerable.
By proactively acting for the most vulnerable and underrepresented, we advance solutions that otherwise might not have been possible, including research for unmet needs.
By empowering our employees to perform local volunteer activities, we strengthen communities where we both live and work.
By signing up to the United Nations Global Compact, we are committed to upholding its principles for sustainable and socially responsible practices, publicly reporting on our implementation efforts since 2003.

How we Minimize Risks

We ensure our commitments to society deliver tangible impact with proper measurement and public reporting.
We value the trust that society places in Sanofi and pursue decisions at every level within our organization that aim to earn and preserve that trust, including the embedding of corporate social responsibility into our leaders’ career development pathway.
We listen to the patients, our employees, business partners, and stakeholders that comprise the communities where we operate to support improved and ethical decision-making.
We recognize that some people are more vulnerable than others and that Sanofi has a responsibility to understand and address their needs.
We support patient health across the world’s diverse communities and do not discriminate against a community based on geographic, social, political or other factors.
We do not undertake decisions to weaken our long-term development and our ability to deliver on our commitments sustainably.

Climate change is one of the most pressing challenges of our time. Sanofi’s immediate and long-term success requires decisive leadership to protect our planet and the natural air, land, and water environment that humanity depends on.
Sanofi is committed to maintaining patient focus as well as acting with integrity, respect, legitimate intent, transparency, and accountability when interacting with stakeholders.

Utilizing Social Media and Communicating Responsibly

At Sanofi, we ensure that our stakeholders can hear from and engage with us, including through social media and digital platforms. We recognize this requires us to communicate responsibly and are fully committed to doing so.

At Sanofi, we use diverse communication channels to support our purpose of advancing the miracles of science to improve people’s lives. Our communications include social media and other public digital platforms. Such platforms can include corporate Sanofi accounts that spotlight our initiatives, accounts that provide scientific information related to our products and therapeutic areas, accounts from company leaders and spokespeople, and accounts managed by individual Sanofi employees. We are committed to ensuring that our activities on these platforms take place in a responsible manner in alignment with industry standards and applicable regulations, including ensuring good promotional practices.

The content published by dedicated and trained teams on corporate accounts reflects our values and our culture. The information we provide is accurate, authentic, and timely. It is designed to be accessible and engaging to diverse stakeholders and communities while encouraging participation and interaction.

How we Maximize Opportunities

By sharing our values, commitments, activities, and scientific information with individuals and stakeholders around the world, Sanofi builds awareness of our purpose, inspires collaboration that drives innovation, and shares accurate, swift, and targeted information to those in need.
By learning from and taking stock of what we receive from individuals and stakeholders via social media and digital platforms, including recommendations to strengthen Sanofi as well as improved capturing and reporting of product complaints and adverse events.
By empowering patients and those with valuable experience or expertise regarding Sanofi’s products and services to share their stories in a manner that supports human health.
By empowering our employees and business partners to engage with, learn from, and contribute to their communities in a responsible and compliant manner.

How we Minimize Risks

We prioritize responsible engagement in all uses of social media and digital platforms.
We maintain an active pharmacovigilance monitoring of our social media channels, ensuring any adverse events or product technical complaints are promptly reported to meet worldwide safety requirements.
We do not permit our employees or business partners to share or comment on confidential information using social media or public digital platforms, and we require them to use good judgement and always reflect Sanofi’s values when engaging on social media.
We are vigilant about user privacy, and transparent about our use of personal data.
We ensure our stakeholders can clearly identify information issued by Sanofi, especially when published by a business partner on our behalf.

Sanofi is committed to data privacy and information security at every level of our organization for the benefit of patients, our employees, and stakeholders and to ensure full compliance with regulatory obligations.
Sanofi strives to deliver better outcomes for patients, communities, and stakeholders by providing groundbreaking therapies at the right time and for the right reasons. We support a level playing field in which companies freely and fairly chase the miracles of science without undue advantage.
Sanofi does not tolerate any form of bribery or abuse of power for personal gain, both among our employees and business partners, as well as among stakeholders involved in chasing the miracles of science to improve patients’ lives.
We are committed to the integrity of Sanofi’s financial activities to realize our purpose, ensuring our role as a trusted partner in serving public health needs and expanding health innovation. Financial integrity is vital to protect the patients we serve as well as our employees, stakeholders, and the financial markets.

Preserving Benefit-Risk Balance

Sanofi is committed to transparent communication about its products, while ensuring information about the efficacy, safety profile and services are routinely updated.

The safety of patients is fundamental to our purpose of improving people’s lives. This starts with protecting those who participate in the clinical trials we sponsor and extends to product safety throughout our manufacturing operations and quality of supply. We guarantee a positive benefit-risk balance of our products. In addition, we safeguard patient privacy, uphold the integrity of patient data, provide information to ensure safe and effective use of our products and services, and continuously monitor and report adverse events. As Sanofi’s products and services evolve and bring even greater opportunities to improve patient health, we will remain steadfast in our commitment to the preservation of patient safety in close collaboration with our stakeholders.

How we Maximize Opportunities

By prioritizing patient safety, Sanofi improves health outcomes, enhances patient confidence in healthcare, and earns vital trust with stakeholders.
By preserving a positive benefit-risk balance for all our products throughout their product lifecycle, Sanofi strengthens its patient-centered approach and is better prepared to address future safety needs, including in promising areas such as gene editing and cell therapy.

How we Minimize Risks

We conform our products and services to stringent standards of quality, safety, efficacy, and risk/benefit analysis, as determined by regulatory authorities wherever we operate.
We secure evidence that our products and services have acceptable safety profiles before they are tested on human research participants.
We provide up-to-date relevant safety and efficacy information to support the decisions of government authorities, investigating sites, and ethics committees in approving our clinical research
We employ a patient-centered informed consent process where prospective clinical trial participants and/or their caregivers understand potential safety risks prior to deciding to voluntarily participate.
We transparently communicate and routinely update information about the safety and efficacy of our products and services throughout their lifecycle.
We support the education of the scientific and medical community by providing accurate, timely, and balanced information about our products and services to ensure their proper use.
We ensure that responses to medical information requests from patients and healthcare professionals are timely, truthful, evidence-based and scientifically balanced to support the informed and appropriate use of Sanofi’s products.
We protect patient privacy and inform patients about how we use their personal data, all in full compliance with applicable laws.
We swiftly report adverse events or adverse reactions to Sanofi’s products to regulatory authorities in accordance with our pharmacovigilance requirements.

Sanofi is committed to the sustainable and long-term success of our company aligned with our strategy. In order to uphold our purpose and ambition, we work with all stakeholders to help ensure our commercialization approach promotes patient and societal welfare, complies with laws and regulations, and operates ethically and with integrity.
At Sanofi, we are committed to conducting our research and development activities with integrity and providing relevant information transparently to facilitate the proper use of our products.

Accelerating Research and Development with Scientific Integrity

At Sanofi, we are committed to conducting our research and development activities with integrity and providing relevant information transparently to facilitate the proper use of our products.

Sanofi seeks to chase the miracles of science to improve people’s lives by prioritizing scientific integrity in all aspects of our work. This means conducting our research and development with the right motivations, in a manner that upholds our ethical principles, and in accordance with applicable regulatory, medical and scientific standards. Such an approach enhances our capabilities and builds trust between Sanofi and our stakeholders, positioning us to drive sustainable innovation.

How we Maximize Opportunities

By embracing the highest standards of scientific integrity in our research, Sanofi attracts and maintains talent and partners that allow us to bring forward new products and services that save lives, underpin our purpose, and fuel our sustained growth.
By committing to publicly disclosing accessible information on our clinical trials and their results, Sanofi builds trust with patients, healthcare professionals, healthcare providers, and the scientific community.
By utilizing Sanofi’s Bioethics Committee, when needed, with additional advice from an external Advisory Bioethics Committee, Sanofi helps to ensure our scientific and medical activities are conducted ethically and with integrity.

How we Minimize Risks

We conduct our research, preserving patients’ rights, and in compliance with all applicable laws, regulations and ethical guidelines related to Good Research Practices, Good Laboratory Practices, and Good Clinical Practices.
We conduct our research with the intent to develop scientific knowledge that will benefit patients while advancing science and medicine.
We conduct internal reviews of any scientific information we deliver to the scientific community, healthcare providers, and to patients, to guarantee compliance with good scientific information practices.
We do not make false or misleading statements nor disseminate scientific information that inaccurately estimates the real value of the product or service and its role in helping the patient.
We ensure transparency and accountability in the presentation of research and publication of study results.
We do not undertake research or clinical trials as an inappropriate inducement for past or future sales.
We are committed to the welfare of animals and the protection of the environment in our research and development.
We routinely review and update Sanofi’s Bioethics Framework to guarantee the integrity of all our scientific and research activities.

Sanofi is committed to the sustainable and long-term success of our company aligned with our strategy. In order to uphold our purpose and ambition, we work with all stakeholders to help ensure our commercialization approach promotes patient and societal welfare, complies with laws and regulations, and operates ethically and with integrity.
Sanofi is committed to transparent communication about its products, while ensuring information about the efficacy, safety profile and services are routinely updated.

Interacting with Stakeholders

Sanofi is committed to maintaining patient focus as well as acting with integrity, respect, legitimate intent, transparency, and accountability when interacting with stakeholders.

To fulfill Sanofi’s purpose, we must interact and partner with diverse stakeholders in the health ecosystem in numerous ways. These stakeholders include patients and patient organizations, caregivers, healthcare professionals, government officials, and scientific and technological organizations, among others. These exchanges are the lifeblood of biopharmaceutical innovation and patient access to our products and services. To advance patient care, our interactions with each stakeholder must align with Sanofi’s ethical principles. This includes sharing a patient and consumer focus and commitment to integrity, recognizing conflicts of interest, respecting mutual independence, embracing transparency, and holding ourselves accountable for the results of our interactions. Sanofi is also committed to productive public discourse and responsible political engagement with stakeholders on issues tied to our mission.

How we Maximize Opportunities

By fostering interactions with stakeholders that are based on trust and ethical principles, and by recognizing potential conflicts of interest, we strengthen the reliability of Sanofi’s performance as well as the sustainability of the health ecosystem in which we operate.
By interacting with patients, patient organizations and caregivers, we better understand patient needs as well as the impact of our products and services, utilizing those learnings to drive continuous improvement in our work.
By respectfully enabling connections among patients and caregivers to share their experiences and needs, we advance research and improve people’s lives.
By providing responsible scientific, educational, clinical, product, and policy information to diverse stakeholders, including patients, caregivers, healthcare professionals, and authorities, we improve patient care and support a level playing field for the innovative products and services we provide.
By utilizing appropriate marketing for our products and services, we help maximize benefits for health systems and patients.

How we Minimize Risks

We commit to proactively detecting, avoiding and/or mitigating conflicts of interest that may emerge during Sanofi’s interactions with stakeholders.
We observe clear ethical boundaries when interacting with patients and caregivers, individually and as part of patient organizations, respecting their autonomy and the voluntary nature of these interactions.
We ensure our financial and in-kind support for patient organizations is transparent and reflected in written agreements.
We interact with healthcare professionals in a transparent and professional manner, consistent with laws and regulations, and without offering or providing anything that could
- (a) inappropriately influence prescribing practices or
- (b) encourage inappropriate use of our products or services.
We inform healthcare professionals about the benefits and risks of our products and services to help advance appropriate prescribing and use by patients.
We organize or sponsor symposia, congresses, informational presentations, and other events for healthcare professionals and patient advocacy groups for the purpose of accurately informing them about scientific research as well as our products and services.
We ensure there is an appropriate bona fide business purpose for any engagement of an external expert stakeholder for consulting and/or speaking services.
We seek recommendations and advice from external experts, for example at advisory boards, and ensure they are not abused to inappropriately influence those experts.
We fully document the nature of each donation made by Sanofi and require from the recipient full disclosure of the donation’s appropriate purpose.

We ensure that access programs are compliant with all applicable laws, regulations and codes, including those pertaining to pharmacovigilance, pricing, patient data protection, and antitrust, as well as with high integrity standards related to interactions with business partners and other stakeholders.
We observe clear and ethical boundaries when interacting with government officials and when undertaking responsible political engagement, providing accurate and balanced information, and prohibiting inappropriate influence in public policy-setting and other decision-making processes.
We do not engage in any activities with stakeholders that are or could be perceived as promotional prior to gaining marketing and other necessary authorizations for our products or services.
We adhere to leading practices on stakeholder interactions reflected in the global, regional or local industry Codes, such as IFPMA Code of Practice and Notes for Guidance.

Our approach to social impact is to strengthen, reaffirm, and amplify our commitment to society and the communities we serve. Our social impact is enabled by three efforts:

Maintaining Financial Integrity

We are committed to the integrity of Sanofi’s financial activities to realize our purpose, ensuring our role as a trusted partner in serving public health needs and expanding health innovation. Financial integrity is vital to protect the patients we serve as well as our employees, stakeholders, and the financial markets.

Therefore, Sanofi’s financial records are designed to ensure that we do not mislead investors, legislators, authorities and the public about financial aspects of our company.

As a publicly listed company, Sanofi has a responsibility to generate and maintain accurate books, records, and accounts as well as to file accurate financial statements that embrace transparency through the public disclosure of material information. In addition to robust internal controls and procedures for financial reporting that foster conformity with generally accepted accounting principles, our financial integrity extends to a strict prohibition on insider trading and money laundering. Sanofi complies with governing tax rules, restrictions on denied or restricted parties, and inquiries from internal and external auditors.

How we Maximize Opportunities

By upholding trust and confidence in our business from the patients we serve as well as our employees, stakeholders, and the financial markets.
By embracing transparency of accurate material information through public disclosure.
By positioning ourselves as a preferred partner in financing and contracting activities that are foundational to our innovation and delivery of products and services for patients.
By making better decisions based on complete, accurate, and timely information.
By enabling the deployment of financial resources for their intended and approved purpose, strengthening our agility to meet business objectives and directing capital where it is needed.
By positioning Sanofi as a leader in strengthening links between our world’s sustainability and our financial performance.

How we Minimize Risks

We maintain robust procedures to generate and maintain complete, accurate, and timely books, records, and accounts that reflect our activities.
We maintain robust controls over financial reporting that enable Sanofi to conform to generally accepted accounting principles.
We maintain confidentiality of material information prior to public disclosure and disclose material non-public information only to persons who need to know this information.
We prohibit trading based on confidential information for personal profit, as well as “tipping” others so they may do so.
We have strong policies that do not tolerate any bribe or other favor to influence a decision of another person or entity that may impact Sanofi’s business.
We provide complete, accurate, and timely responses to internal and external auditors who evaluate our financial statements.
We conduct reviews to comply with restrictions on denied or restricted parties.
We uphold rules and programs to prevent and combat money laundering.
We fulfill our role as a responsible corporate organization by paying taxes in the jurisdictions in which we operate.
We adhere to a formal contracting process in order to maintain the rights we have granted and obligations we have undertaken with persons or entities outside Sanofi.

Sanofi is committed to data privacy and information security at every level of our organization for the benefit of patients, our employees, and stakeholders and to ensure full compliance with regulatory obligations.
Sanofi strives to deliver better outcomes for patients, communities, and stakeholders by providing groundbreaking therapies at the right time and for the right reasons. We support a level playing field in which companies freely and fairly chase the miracles of science without undue advantage.
Sanofi does not tolerate any form of bribery or abuse of power for personal gain, both among our employees and business partners, as well as among stakeholders involved in chasing the miracles of science to improve patients’ lives.
At Sanofi, we ensure that our stakeholders can hear from and engage with us, including through social media and digital platforms. We recognize this requires us to communicate responsibly and are fully committed to doing so.

Sustaining Good Operating Practices

At Sanofi we manufacture and distribute products of the highest quality worldwide to improve people’s lives.

At Sanofi, we are proud of our products, and we value patient and stakeholder trust in them. To earn and sustain that trust, we manufacture and package our products according to the highest quality standards. We rely on our dedicated people who work in our factories and on cutting-edge technologies to ensure product quality throughout its lifecycle. We seek continuous improvement in our manufacturing standards and ensure alignment with all applicable regulatory requirements and current good manufacturing practices. We work closely with worldwide health authorities to maintain all necessary licenses and certificates to operate our production facilities. We regularly audit our industrial sites, suppliers, and other business partners to ensure the highest quality of our products and their components.

We apply Good Distribution Practices to ensure that our products are transported under conditions guaranteeing their security and quality.

How we Maximize Opportunities

By cultivating a culture of quality to pursue continuous improvement and innovation, embrace the benefits of new technologies and optimize risk taking throughout our organization.
By adhering to the highest quality standards in our operating practices, we help ensure the best medicines reach those who need them while safeguarding patient and stakeholder trust in our medicines.
By routinely implementing proven technologies into our operating practices that allow Sanofi to offer new and best-in-class medicines.
By leveraging digital solutions to improve our manufacturing, packaging, supply operations.
By enhancing our methods to produce active ingredients.
By maintaining a strong supply chain to ensure access to Sanofi medicines worldwide and on time.

How we Minimize Risks

We systematically identify and manage health, safety, and environmental risks over the entire value chain of our products and services.
We manufacture high-quality products that meet all regulatory requirements and pursue quality beyond compliance with regulation in both our products and processes.
We protect patient safety by identifying, assessing, and managing any product-related risks in a timely manner.
We are highly committed to ensure Quality in researching, developing, and providing safe and efficacious products for our patients.
We closely engage with regulatory authorities to ensure compliance with their requirements.
We ensure oversight of our supply chain and product deliveries and transport medicines under conditions guaranteeing their security and quality.
We perform regular audits of Sanofi industrial sites, suppliers, and other business partners to ensure that only products that meet our high-quality standards are made and delivered.

Sanofi is committed to the sustainable and long-term success of our company aligned with our strategy. In order to uphold our purpose and ambition, we work with all stakeholders to help ensure our commercialization approach promotes patient and societal welfare, complies with laws and regulations, and operates ethically and with integrity.
Sanofi is committed to transparent communication about its products, while ensuring information about the efficacy, safety profile and services are routinely updated.
At Sanofi, we are committed to conducting our research and development activities with integrity and providing relevant information transparently to facilitate the proper use of our products.

Transforming Medicine through Digital Health

Sanofi is leveraging technology to transform the practice of medicine and create a safe and ethics-by-design environment for digital solutions.

Our ambition is to be the world’s leading digital healthcare platform. Using digital applications, portals, Artificial Intelligence (AI), digital biomarkers, data analytics and evolutive industrial facilities, Sanofi is creating a more agile, integrated and highly collaborative digital environment to boost performance across the entire organization. This includes digital innovation for accelerated approaches to research and development, strengthened digital engagement with healthcare professionals, and specific digital patient support solutions and robust digital tools.

How we Maximize Opportunities

By accelerating our digital transformation and ways of working to be the leading digital healthcare platform, we aim to develop and deliver our products faster, to leverage data insights and engage in full digital experiences.
By launching and refining our Digital Accelerator, we have an agile delivery platform to build strategic digital products such as: AI-based omnichannel engines, healthcare professional portals, digital commerce platforms, and other technologies to drive our transformation.
By launching state-of-the-art, scalable digital applications in our research and development programs, we increase our understanding of diseases, shorten the diagnostic journey, and strengthen patient care.
By establishing a global strategy for AI and data democratization, and by expanding our analytics capabilities through machine-learning platforms and digital biomarkers identification, we are:
- bettering the understanding of diseases to develop new medicines,
- accelerating, optimizing and diversifying patient recruitment for our clinical studies.
By harnessing AI’s potential responsibly, we drive innovation at-scale both internally across our organization, and externally to better serve our stakeholders and our patients in a manner that prioritizes fairness, transparency, safety, eco-sustainability, and accountability.
By launching a global digitalization strategy for our industrial manufacturing operations, we are transforming our sites into highly efficient and sustainable “Factories of the Future” where objects, infrastructure and people are interconnected, enhancing the reliability of production and customer service, and catalyzing the move towards carbon neutral production.

By implementing an ethics-by-design approach into our digital transformation, we strengthen our long-term resilience and foster a culture of transparency, fairness, trust and accountability, quality, and non-discrimination across the global ecosystem of health innovation.

How we Minimize Risks

We implement and routinely enhance our Digital Control Framework, which includes all controls our digital healthcare solutions have to comply with.
We utilize a structured, end-to-end framework for digital solutions, providing a common and transparent view of digital governance and operational processes that reinforces ethics-by-design approaches.
We take on accountability from design through deployment and use of AI systems, including those from third parties, by adhering to a comprehensive thoughtful risk-taking framework that is responsive to the changing AI regulatory landscape, and enforces proportionate governance and technology controls to manage AI innovation responsibly.
We ensure close coordination with Sanofi’s data privacy, IT security and cybersecurity teams to ensure personal data are used in accordance with all applicable laws.

Sanofi is committed to the sustainable and long-term success of our company aligned with our strategy. In order to uphold our purpose and ambition, we work with all stakeholders to help ensure our commercialization approach promotes patient and societal welfare, complies with laws and regulations, and operates ethically and with integrity.
Sanofi is committed to transparent communication about its products, while ensuring information about the efficacy, safety profile and services are routinely updated.
At Sanofi, we are committed to conducting our research and development activities with integrity and providing relevant information transparently to facilitate the proper use of our products.

At Sanofi, we chase the miracles of science to improve people’s lives.

This common purpose, bold yet humble, unites all Sanofi employees across the world in our ongoing quest to make life better for the people and communities we serve. It is the compass that guides us in the work we do every day.

But our purpose is more than just words; it’s the actions we take to earn the trust of our stakeholders – and the way we show up for one another – that really matters. Embracing our Play to Win behaviors, sticking to a clear, long-term strategy and creating a culture that allows people to bring their whole selves to work, ignites our progress while maintaining the utmost ethical standards.

Our Code of Conduct summarizes all these elements.

It is our company’s “constitution” and a pre-requisite, mandatory read for all Sanofi employees and those we do business with.

It also represents a public commitment to our stakeholders – healthcare professionals, patients, scientists, investors – who are entitled to know what we as Sanofians value and how we are playing to win with integrity.

As a world leader in healthcare, we have a responsibility to be both ethical in our endeavors while also striving for change that matters. It is our mission to contribute to elevating the voice of patients, highlighting the importance of scientific innovation, and building sustainable healthcare systems with all of our stakeholders.

Just as our society continues to evolve and modernize, so must we. Whether technological, scientific or cultural, we are always adapting. The data and digital revolution has only begun to reshape healthcare systems. The mobilization for greater social justice and equity calls for quick, concrete corporate actions. The fight against climate change requires long-term planning. As a company, we must understand and mitigate the risks these evolutions can have on our operations and reputation, and, of equal importance, leverage the opportunities they can bring to help us create real, measurable impact.

Every employee has a responsibility to uphold Sanofi’s values and a role to play in driving our success as a modern healthcare company. A company that is always focused on conducting business responsibly and respecting human rights. A company that takes thoughtful risks to develop breakthrough medicines and vaccines and make them accessible to people who need them as quickly as possible. A company that puts diversity, equity and inclusion, as well as health and environmental sustainability at the core of its ambitions. A company that is always focused on doing the right thing, the right way.

We work in an industry whose purpose is to innovate to save people’s lives and preserve public health.

Such a unique purpose comes with heightened expectations. Responsible innovation is therefore at the heart of everything we do and this Code of Conduct supports us along that journey.

As the world confronts tremendous change and technological innovation grows exponentially, we venture into the unknown in the pursuit of the miracles of science. Many of the decisions and challenges we will face will be less black or white, but a lot grayer. Ethics and innovation will be our compass, guiding us and allowing us to succeed in our mission to discover the extraordinary. It will differentiate us from the others: what we call Play-to-Win with Integrity.

The traditional boundaries of the company are broadening and shifting from enterprise to ecosystem. Hence our conviction that Sanofi’s commitment to integrity must extend beyond our employees and business partners. This includes our engagement with patients, healthcare professionals, providers, payers, authorities, NGOs, IGOs and many more to shape a responsible healthcare ecosystem.

Improving the lives of millions of people around the world through ground-breaking health innovation requires a culture that is driven by trust, integrity and thoughtful risk-taking.

Avoiding excessive caution and carelessness allows us to find the right balance between opportunities and risks, to make bold and informed choices, always putting patients first.

Ethics-by-design, Thoughtful Risk Taking, simplified ways of working, co-design with stakeholders, sustainability and transparency are fundamental building blocks of our strategy.

Tomorrow’s most valuable and enduring companies will be those that support such efforts today.

Having the courage to do the right thing, at the right time and for the right reason, by upholding our commitment to integrity every day in each act we undertake is our True North. This is rooted in organizational justice and psychological safety, including an openness to speak-up, challenge the status quo and give opinions without fear of retaliation.

This Code of Conduct covers the dimensions we believe are essential to achieving our commitment to patients and society, including our actions to maximize opportunities and mitigate risks in each of these areas of our business.

Our employees and partners have access to a variety of resources and initiatives supporting the Code of Conduct. We also recognize the rapidly changing landscape we work in and Sanofi is dedicated to continuous learning and improvement over time.

We count on all of you to Play Your Part and become true ambassadors of our Code of Conduct. That’s how we will accelerate our cultural transformation and pursue our noble purpose.